China drugmakers axe IPO plans as they face scrutiny in anti-graft drive

Source:

Key Topics in this News Article:

China Electronics Healthcare Investment IPO Medicine Pharmaceutical Shanghai

News Snapshot:

News Timeline | Services | Contact | About | Privacy

© 2024 ChinaPulse.com. Individual news stories are copyright their respective sources. Computer algorithms generally select what is shown on ChinaPulse.com. The algorithms determine which stories, images, and videos show, and in what order. A service of Asia Media Network.